908 Devices Inc. (NASDAQ:MASS) Shares Sold by Nikko Asset Management Americas Inc.

Nikko Asset Management Americas Inc. trimmed its holdings in 908 Devices Inc. (NASDAQ:MASS) by 5.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 467,427 shares of the company’s stock after selling 27,795 shares during the quarter. Nikko Asset Management Americas Inc. owned about 1.34% of 908 Devices worth $1,024,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the business. Drive Wealth Management LLC bought a new stake in shares of 908 Devices during the 3rd quarter worth about $50,000. Connor Clark & Lunn Investment Management Ltd. bought a new stake in 908 Devices during the third quarter worth approximately $190,000. Charles Schwab Investment Management Inc. lifted its position in 908 Devices by 14.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 220,477 shares of the company’s stock worth $765,000 after purchasing an additional 28,015 shares during the period. 49 Wealth Management LLC boosted its stake in 908 Devices by 16.2% during the 3rd quarter. 49 Wealth Management LLC now owns 31,099 shares of the company’s stock valued at $108,000 after purchasing an additional 4,343 shares in the last quarter. Finally, Townsquare Capital LLC acquired a new position in shares of 908 Devices during the 3rd quarter valued at $50,000. Institutional investors own 88.06% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on MASS. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of 908 Devices in a research note on Friday, March 7th. Stephens restated an “overweight” rating and set a $6.00 price objective on shares of 908 Devices in a research report on Wednesday, January 15th. Two research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $5.33.

908 Devices Trading Up 11.4 %

Shares of MASS opened at $4.58 on Tuesday. The business’s 50-day moving average price is $2.74 and its 200 day moving average price is $2.91. The stock has a market capitalization of $161.81 million, a P/E ratio of -2.59 and a beta of 0.99. 908 Devices Inc. has a 1-year low of $1.81 and a 1-year high of $7.56.

About 908 Devices

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.